BiotechTube

SRP-9003 + Glucocorticoid

Phase 3Active
0 watching 0 views this week📈 Rising
72
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Limb-girdle Muscular Dystrophy

Conditions

Limb-girdle Muscular Dystrophy

Trial Timeline

Jan 15, 2024 → Nov 30, 2029

NCT ID
NCT06246513

About SRP-9003 + Glucocorticoid

SRP-9003 + Glucocorticoid is a phase 3 stage product being developed by Sarepta Therapeutics for Limb-girdle Muscular Dystrophy. The current trial status is active. This product is registered under clinical trial identifier NCT06246513. Target conditions include Limb-girdle Muscular Dystrophy.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT06246513Phase 3Active

Competing Products

3 competing products in Limb-girdle Muscular Dystrophy

See all competitors
ProductCompanyStageHype Score
DeflazacortPTC TherapeuticsPhase 3
74
SRP-9005 + CorticosteroidSarepta TherapeuticsPhase 3
72
ATYR1940 + PlaceboaTyr PharmaPhase 1/2
33

Other Products from Sarepta Therapeutics

Golodirsen 50 MG/1 ML Intravenous Solution [VYONDYS 53]Approved
80
EteplirsenPhase 3
72
SRP-9005 + CorticosteroidPhase 3
72
Casimersen + GolodirsenPhase 3
72
eteplirsenPhase 3
72